After decades of research and clinical trials, vaccines are beginning to impact patient outcomes and pushing the boundaries of research in the field of immuno-oncology. While the future is bright, we still have a long way to go. This year, the third edition of the event will be an international meeting for experts to share and discuss the latest findings and future perspectives on cancer vaccines and immunotherapy.